FDA Grants Orphan Drug Designation for CAN-2409 to Treat Pancreatic Cancer

1 year ago 35

The designation was granted based on overall survival data from an ongoing randomized phase 2 clinical trial.

1. Homepage
2. category-label-
3. FDA Grants Orphan Drug Designation for CAN-2409 to Treat Pancreatic Cancer